Johnson & Johnson begins testing its COVID-19 vaccine in children as young as 12
Johnson & Johnson is now testing its COVID-19 vaccine in children and teenagers between ages 12 and 17. U.S. regulators have authorized the firm’s one-dose shot for adults 18 and older. The trial expansion will first test J&J’s shot in teens aged 16 to 17. If the vaccine appears to be safe and prompt an … Read more